«Salpingitis

Below is an extended Salpingitis patents listing. Click here to return to the Salpingitis main in depth entry.

Patents :
US Patent No.	Title
7067493	Single dose azithromycin
7151085	Therapeutic methods using cyclosporine components
7157430	(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
7163797	50 human secreted proteins
7172863	Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7183260	C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
7189405	Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7208574	Host receptor for pathogenic bacteria
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7138516	Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
7070791	Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunoassay
7070792	Chlamydia antigens and corresponding DNA fragments and uses thereof
7078193	Pathogenic Escherichia coli associated protein espA
7078399	Sulfhydryl rifamycins and uses thereof
7087742	Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
7090972	Methods for determining the presence of non-viral organisms in a sample
7091315	Protein HDPBQ71
7097860	Method and composition for treatment of inflammatory and inflammation-related disorders
7105171	Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
7109302	Antibodies that specifically bind to GMAD
7214499	Pathogenic Escherichia coli associated protein
7220738	Rifamycin analogs and uses thereof
7220827	Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
7326545	Chlamydia antigens and corresponding DNA fragments and uses thereof
7342011	Rifamycin analogs and uses thereof
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7375192	Antibodies that specifically bind to chemokine beta-4
7381800	Antibodies to HBIMF63 polypeptide
7384969	N-(1H-indolyl)-1H-indole-2-carboxamide derivatives, their preparation and their therapeutic use
7385034	Complementary DNAs encoding proteins with signal peptides
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7407950	N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands
7314869	Chlamydia antigens and corresponding DNA fragments and uses thereof
7306805	Nontypeable Haemophilus influenzae virulence factors
7229975	DNA immunization against chlamydia infection
7232667	Keratinocyte growth factor-2 polynucleotides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7241867	Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome
7247714	Protection against oxidative stress and inflammation by a cytoprotective response element
7253275	Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
7270960	Diagnosis of ovarian carcinomas
7271165	Rifamycin analogs and uses thereof
7271243	Full-length human cDNAs encoding potentially secreted proteins
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.